Respiratory allergies are today a major public health issue.
Pollen and spore counts are essential for allergists and people living with allergies, as they represent a key indicator for monitoring pollen seasons. However, they do not always fully explain the actual severity of symptoms observed.
Air allergenicity also depends on the amount of allergens effectively present and inhaled, particularly during periods of high pollination, when pollen grains fragment and release allergenic proteins. Direct measurement of these allergens, such as Bet v 1 from birch pollen — a major pollen source across Europe — provides a more representative assessment of real exposure.
To make such analyses possible, the quality of air sampling is critical. This is the context of our Application Note, which relies on the Coriolis+ air sampler. Thanks to its liquid‑phase collection technology, Coriolis+ enables efficient capture of bioaerosols under real‑world conditions. The resulting samples are directly compatible with rapid microbiological and immunological analysis methods.
This approach helps strengthen the correlation between environmental data and clinical observations, paving the way for improved understanding and anticipation of allergic episodes.
